Skip to content

Greywolf Therapeutics vs Immunaeon

Greywolf Therapeutics logo

Greywolf Therapeutics

We are advancing novel antigen modulation technology that controls T cells to guide the immune system

49 employees · est. 2017 · United Kingdom

VS
Immunaeon logo

Immunaeon

Connecting Today's Science to Tomorrow's Cures

5 employees · est. 2019 · Buffalo, United States

Greywolf Therapeutics is the older company (2017 vs 2019); Greywolf Therapeutics is the larger of the two.

Side-by-Side Comparison

Greywolf Therapeutics Immunaeon
Founded
2017 older 2019
Headquarters
United Kingdom Buffalo, United States
Employees
49 larger 5
Industry
Biotechnology, Health Care, Health and Wellness Biopharma, Biotechnology, Health Care
Funding Stage
Series B Not tracked yet
Total Funding
$107.10M $480.00K
Funding Rounds
5 4
Services
Development of antigen modulation technology for therapeutic treatments in oncology, autoimmunity, and virology immune cell isolation, cell analysis and preservation, immunotherapy preparation, health resilience planning
Target Customers
Patients with cancers, autoimmune disorders, and infectious diseases individuals with a family history of cancer, individuals with autoimmune disorders, health-conscious individuals, patients seeking proactive healthcare
Taxonomy
BiotherapeuticsImmunotherapyCancer TreatmentAutoimmune DisordersInfectious DiseasesT Cell Activation +4 ImmunotherapyGenetic SciencesComputational SciencesPrecision-targeted TherapeuticsCellular BiologyCancer Treatment +8
Website
greywolftherapeutics.com immunaeon.com
Greywolf Therapeutics logo

About Greywolf Therapeutics

Greywolf Therapeutics is a biotechnology startup based in the United Kingdom, founded in 2017. The company is focused on solving immune dysfunction by advancing novel antigen modulation technology that guides the immune system. Their approach addresses the challenge of T cells not being able to reco...

Immunaeon logo

About Immunaeon

Immunaeon, known for its slogan "Connecting Today's Science to Tomorrow's Cures", is a biotech pioneer established in 2019 in the United States. The company positions itself at the forefront of immunotherapy and biotechnology innovation, aiming to transform healthcare by leveraging advanced genetics...

Also comparing in this category

Comparing more than these two?

Get Greywolf Therapeutics, Immunaeon and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Greywolf Therapeutics compare?

A PDF of Greywolf Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Greywolf Therapeutics was founded in 2017, based in United Kingdom, with 49 employees. Greywolf Therapeutics is a biotechnology startup based in the United Kingdom, founded in 2017. The company is focused on solving immune dysfunction by advancing novel antigen modulation technology tha. Immunaeon was founded in 2019, based in Buffalo, United States, with 5 employees. Immunaeon, known for its slogan "Connecting Today's Science to Tomorrow's Cures", is a biotech pioneer established in 2019 in the United States. The company positions itself at the forefront of immuno.
Greywolf Therapeutics has raised $107.10M and Immunaeon $480.00K. Latest stage: Greywolf Therapeutics Series B.
Both work in Biotechnology, Health Care and Health and Wellness and list immunotherapy, cancer treatment and autoimmune disorders among their focus areas.

Compare Greywolf Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Greywolf Therapeutics on 25 Feb 2025, and Immunaeon on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout